The aim of this study is to investigate the association between genetically proxied circulating PD-1 and PD-L1 protein levels and survival of seven cancer types (breast, colorectal, head and neck, lung, melanoma, ovarian and prostate). This evidence concerns the gene PDCD1 and cancer.